U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C18H20N2O3
Molecular Weight 312.363
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 25CN-NBOH

SMILES

COC1=CC(CCNCC2=C(O)C=CC=C2)=C(OC)C=C1C#N

InChI

InChIKey=VWEDZTZAXHMZIL-UHFFFAOYSA-N
InChI=1S/C18H20N2O3/c1-22-17-10-15(11-19)18(23-2)9-13(17)7-8-20-12-14-5-3-4-6-16(14)21/h3-6,9-10,20-21H,7-8,12H2,1-2H3

HIDE SMILES / InChI

Molecular Formula C18H20N2O3
Molecular Weight 312.363
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

25CN-NBOH (or NBOH-2C-CN) is a compound indirectly derived from the phenethylamine series of hallucinogens, which was discovered in 2011 by Martin Hansen at the University of Copenhagen. This compound is notable as one of the most selective agonist ligands for the 5-HT2A receptor yet discovered, with a pKi of 8.88 at the human 5-HT2A receptor and with 100x selectivity for 5-HT2A over 5-HT2C, and 46x selectivity for 5-HT2A over 5-HT2B

CNS Activity

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
1.3 nM [Ki]

Conditions

ConditionModalityTargetsHighest PhaseProduct

PubMed

Sample Use Guides

In Vivo Use Guide
Male NIH Swiss mice were used for activity evaluation. On experimental days, mice were weighed, marked, and returned to the home cage. Doses were then calculated and prepared for intraperitoneal (ip) injection. To generate dose effect functions, individual animals were removed from the home cage, injected with saline or various doses of 25CN-NBOH (0.3, 3 and 10mk/kg) and placed into an observation cage containing fresh bedding. Ten minutes following this injection, an overhead camera was activated and behavior was recorded for 10 min.
Route of Administration: Intraperitoneal
In Vitro Use Guide
The day after transfection, tsA201 cells were split into poly-D-lysine-coated 96-well tissue culture plates in inositol-free DMEM supplemented with 10% dialyzed fetal bovine serum, penicillin (100 U mL−1), streptomycin (100 mg mL−1), and 4 μCi mL−1 myo-[2-3H]inositol (GE Healthcare, Buckinghamshire, U.K.). Two days after transfection, cells were washed with assay buffer 1 (Hanks’ balanced saline solution (HBSS) containing 20 mM HEPES, 1 mM CaCl2, 1 mM MgCl2, and 1 mg mL−1 BSA, pH 7.4) and preincubated in 100 μL assay buffer 1 for 4 h at 37 °C, where the buffer was replaced after 2 h. The cells were then washed and subsequently incubated in 50 μL of assay buffer 2 (HBSS containing 1 mM CaCl2, 1 mM MgCl2, and 20 mM LiCl) for 30 min at 37 °C. Following this incubation, the cells were stimulated with 50 μL of the NBOH-2C-CN in assay buffer 2 for 30 min at 37 °C. The reactions were stopped by exchanging the buffer with 50 μL ice-cold 10 mM formic acid and incubating the cells at 4 °C for at least 30 min. Yttrium silicate scintillation proximity assay beads (GE Healthcare, Buckinghamshire, U.K.) were used for measuring radioactivity from generated [3H]-IP
Substance Class Chemical
Record UNII
32CN2DQE3Q
Record Status Validated (UNII)
Record Version